Drug intelligence / Profile preview

PRM-001

Development stage
Unknown
Lead developer
PharmaResearch
Modality
DNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intradermal
01

Overview

PRM-001 is a polynucleotide (PN) based injectable skin enhancer developed by PharmaResearch Co., Ltd. for aesthetic and regenerative medicine. Composed of long-chain DNA fragments derived from salmon germ cells, PRM-001 functions as a "skin booster" rather than a traditional volumizing filler. Its mechanism of action involves the activation of adenosine A2A receptors, which modulates inflammatory responses and stimulates fibroblast proliferation and collagen synthesis. Additionally, it provides a structural scaffold in the extracellular matrix and supplies nucleotides for the DNA salvage pathway, promoting endogenous tissue repair. PRM-001 is specifically being evaluated in clinical trials for the treatment of periorbital wrinkles, commonly known as crow's feet lines, to improve skin elasticity, hydration, and overall texture.

Brand names
Rejuran
Other names
polynucleotidepolynucleotide sodiumPN
02

Targets

ADORA2A (Adenosine A₂A Receptor)

Beyond the preview

Go deeper on PRM-001.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PRM-001.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call